FREE Shipping on orders $150+
Cardiogen 20mg
Cellular Research

Cardiogen 20mg

Synthetic tetrapeptide bioregulator

99% purity

Research-grade Cardiogen 20mg. 99% purity, third-party tested with published COA.

$50.00

Ships from USA

2–3 business days

Free shipping

On orders $150+

1
  • Same-day shipping on orders before 2pm ET
  • Shipment Protection: lost or damaged orders reshipped free

Compound details

Molecular formula
C18H31N7O9
Molecular weight
489.5 g/mol
Sequence
Ala-Glu-Asp-Arg (AEDR)

Reference chemistry (free base) from public chemical databases and peer-reviewed literature. For laboratory research identification only.

Research use only. This vial is bound for the lab bench, supplied for in-vitro scientific work exclusively and never for administration to any person or animal.

Cardiogen 20mg

$50.00

About Cardiogen

Cardiogen is a linear tetrapeptide of four L-amino acids, Ala-Glu-Asp-Arg (AEDR; ~C18H31N7O9, ~489.5 g/mol), one of the short "bioregulator" peptides characterized in the work of V. Kh. Khavinson and colleagues.

In a peer-reviewed study, the AEDR tetrapeptide was reported to increase expression of cytoskeletal proteins (actin, tubulin, vimentin) and nuclear-matrix proteins (lamins A and C) in cultured mouse embryonic fibroblasts. Published research on this peptide is preclinical and originates primarily from a single research group using in vitro systems; independent replication is limited. Note that "Cardiogen" is also an unrelated nuclear-cardiology product name (the Cardiogen-82 rubidium-82 generator) — a different product, not this peptide.

Frequently asked questions

What is Cardiogen?

Cardiogen is a trade name for a synthetic tetrapeptide, sequence Ala-Glu-Asp-Arg (AEDR), studied as a short peptide bioregulator in the Khavinson research framework. It is supplied for laboratory research use only.

What is Cardiogen peptide?

It is a four-amino-acid (tetrapeptide) research compound, Ala-Glu-Asp-Arg, examined in preclinical cell and tissue studies for effects on protein and gene expression. It is not a therapeutic product.

What is the sequence of Cardiogen?

The sequence is Ala-Glu-Asp-Arg (AEDR), a linear synthetic tetrapeptide of L-amino acids (~C18H31N7O9, ~489.5 g/mol).

What has Cardiogen been studied for in research?

In published preclinical work, the AEDR peptide was reported to increase expression of cytoskeletal proteins (actin, tubulin, vimentin) and nuclear-matrix proteins (lamins A and C) in cultured fibroblasts. These are laboratory findings in cell models and do not establish any effect in humans.

Is Cardiogen approved for human use?

No. Cardiogen (AEDR) is not approved by the FDA or any comparable authority and has no established human clinical use. Published data are preclinical only. It is intended solely for in vitro research.

Research references

Independent databases and peer-reviewed literature for Cardiogen. Provided for research reference only.

External resources are independent and not affiliated with or endorsed by PHIOGEN. Listed for laboratory research reference only.

Related products